Looks like you were able to saved quite a bit on that trade. What made you decide to sell some this morning at $3.30? I thought the stock looked to be going up moderately and should not have dropped to $2 today. I think they are going to start dosing that 75 patient trial tomorrow in NY. That will be in patients that are not severe to see if they recover sooner and never get to severe. That wouldn’t make this a great product as treatment, still not a vaccine though.